Goetz Kathleen bought HQL
April 9, 2024 · Form 4 insider transaction
Goetz Kathleen bought 400 shares of Abrdn Life Sciences Investors at $13.32 per share, a transaction worth $5.3K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
400
Price
$13.32
Total value
$5.3K
InsiderGoetz Kathleen
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateApril 9, 2024
Filing dateApril 12, 2024
Shares owned after1,085
OwnershipDirect
10b5-1 planNo
AmendedNo